| 0 |
ADHESIVE TAPE USE |
141 |
0.3672 |
| 1 |
INTENTIONAL REMOVAL OF DRUG DELIVERY SYSTEM BY PATIENT |
14 |
0.2154 |
| 2 |
MYCOBACTERIAL PERITONITIS |
19 |
0.2000 |
| 3 |
DISTURBANCE IN SOCIAL BEHAVIOUR |
452 |
0.1917 |
| 4 |
RESPIRATORY TRACT MALFORMATION |
24 |
0.1805 |
| 5 |
PULMONARY MALFORMATION |
57 |
0.1624 |
| 6 |
MYCOBACTERIUM FORTUITUM INFECTION |
22 |
0.1189 |
| 7 |
EDUCATIONAL PROBLEM |
181 |
0.1088 |
| 8 |
PRODUCT INEFFECTIVE |
83 |
0.1056 |
| 9 |
DERMAL ABSORPTION IMPAIRED |
29 |
0.1036 |
| 10 |
APPLICATION SITE OEDEMA |
31 |
0.0957 |
| 11 |
HIGH RISK SEXUAL BEHAVIOUR |
14 |
0.0773 |
| 12 |
OPPOSITIONAL DEFIANT DISORDER |
30 |
0.0759 |
| 13 |
LUNG CYST |
29 |
0.0738 |
| 14 |
DECREASED EYE CONTACT |
22 |
0.0724 |
| 15 |
INCORRECT STORAGE OF DRUG |
118 |
0.0682 |
| 16 |
APPLICATION SITE BLEEDING |
16 |
0.0648 |
| 17 |
APPLICATION SITE ERYTHEMA |
1699 |
0.0648 |
| 18 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
680 |
0.0644 |
| 19 |
CHANGE IN SUSTAINED ATTENTION |
19 |
0.0631 |
| 20 |
APPLICATION SITE URTICARIA |
140 |
0.0623 |
| 21 |
DRUG ADMINISTRATION ERROR |
1901 |
0.0619 |
| 22 |
CHOREOATHETOSIS |
40 |
0.0589 |
| 23 |
OBSESSIVE-COMPULSIVE SYMPTOM |
21 |
0.0569 |
| 24 |
DRUG PRESCRIBING ERROR |
1079 |
0.0561 |
| 25 |
APPLICATION SITE IRRITATION |
659 |
0.0529 |
| 26 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1772 |
0.0487 |
| 27 |
RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER |
19 |
0.0473 |
| 28 |
APPLICATION SITE EROSION |
60 |
0.0465 |
| 29 |
LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR |
27 |
0.0462 |
| 30 |
CATAPLEXY |
65 |
0.0459 |
| 31 |
EXPOSURE VIA DIRECT CONTACT |
42 |
0.0442 |
| 32 |
INCORRECT DRUG ADMINISTRATION DURATION |
1191 |
0.0423 |
| 33 |
PRECOCIOUS PUBERTY |
24 |
0.0420 |
| 34 |
LACTATION DISORDER |
20 |
0.0411 |
| 35 |
LIPOPROTEIN (A) INCREASED |
13 |
0.0398 |
| 36 |
DEFIANT BEHAVIOUR |
12 |
0.0390 |
| 37 |
PRODUCT QUALITY ISSUE |
5247 |
0.0386 |
| 38 |
NO ADVERSE EVENT |
6896 |
0.0380 |
| 39 |
POOR SUCKING REFLEX |
15 |
0.0378 |
| 40 |
APPLICATION SITE LACERATION |
15 |
0.0362 |
| 41 |
APPLICATION SITE PRURITUS |
812 |
0.0358 |
| 42 |
NEGATIVISM |
27 |
0.0356 |
| 43 |
IMPULSIVE BEHAVIOUR |
133 |
0.0354 |
| 44 |
TIC |
191 |
0.0350 |
| 45 |
APPLICATION SITE SWELLING |
168 |
0.0337 |
| 46 |
DERMATILLOMANIA |
20 |
0.0336 |
| 47 |
THERAPEUTIC PRODUCT INEFFECTIVE |
128 |
0.0331 |
| 48 |
TRICHOTILLOMANIA |
19 |
0.0324 |
| 49 |
PSYCHOMOTOR HYPERACTIVITY |
524 |
0.0315 |
| 50 |
DRUG EFFECT INCREASED |
99 |
0.0313 |
| 51 |
LOGORRHOEA |
104 |
0.0295 |
| 52 |
KERATOCONUS |
11 |
0.0293 |
| 53 |
APPLICATION SITE DRYNESS |
98 |
0.0288 |
| 54 |
SLEEP-RELATED EATING DISORDER |
26 |
0.0277 |
| 55 |
HYPERKINESIA |
58 |
0.0273 |
| 56 |
APPLICATION SITE DISCOLOURATION |
110 |
0.0270 |
| 57 |
APPLICATION SITE ULCER |
19 |
0.0268 |
| 58 |
PARASOMNIA |
19 |
0.0264 |
| 59 |
SEXUALLY INAPPROPRIATE BEHAVIOUR |
12 |
0.0258 |
| 60 |
DRUG EFFECT DELAYED |
114 |
0.0251 |
| 61 |
PRODUCT ADHESION ISSUE |
896 |
0.0251 |
| 62 |
APPLICATION SITE BRUISE |
24 |
0.0247 |
| 63 |
APPLICATION SITE RASH |
337 |
0.0245 |
| 64 |
SELF-DESTRUCTIVE BEHAVIOUR |
21 |
0.0241 |
| 65 |
HALLUCINATION, TACTILE |
16 |
0.0240 |
| 66 |
DISTRACTIBILITY |
27 |
0.0234 |
| 67 |
ACCIDENTAL EXPOSURE |
97 |
0.0233 |
| 68 |
APPLICATION SITE SCAB |
50 |
0.0231 |
| 69 |
PRE-EXISTING CONDITION IMPROVED |
142 |
0.0227 |
| 70 |
CORONARY ARTERY DISSECTION |
19 |
0.0221 |
| 71 |
ENURESIS |
89 |
0.0220 |
| 72 |
NARCOLEPSY |
41 |
0.0217 |
| 73 |
APPLICATION SITE PAIN |
461 |
0.0209 |
| 74 |
APPLICATION SITE HYPERSENSITIVITY |
25 |
0.0206 |
| 75 |
DEVICE ADHESION ISSUE |
304 |
0.0198 |
| 76 |
MUSCLE CONTRACTURE |
40 |
0.0197 |
| 77 |
PRODUCT ADMINISTRATION ERROR |
397 |
0.0196 |
| 78 |
PRESCRIPTION FORM TAMPERING |
15 |
0.0195 |
| 79 |
APPLICATION SITE DISCOMFORT |
34 |
0.0189 |
| 80 |
PRODUCT ADMINISTRATION INTERRUPTED |
144 |
0.0183 |
| 81 |
APPLICATION SITE INFLAMMATION |
25 |
0.0181 |
| 82 |
DISSOCIATIVE DISORDER |
13 |
0.0180 |
| 83 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
73 |
0.0173 |
| 84 |
DISTURBANCE IN ATTENTION |
916 |
0.0170 |
| 85 |
URTICARIA GENERALISED |
11 |
0.0169 |
| 86 |
APPLICATION SITE BURN |
82 |
0.0166 |
| 87 |
OROMANDIBULAR DYSTONIA |
12 |
0.0165 |
| 88 |
APPLICATION SITE WARMTH |
21 |
0.0165 |
| 89 |
STEREOTYPY |
15 |
0.0159 |
| 90 |
APPLICATION SITE VESICLES |
103 |
0.0159 |
| 91 |
APPLICATION SITE EXFOLIATION |
64 |
0.0155 |
| 92 |
EXCESSIVE EYE BLINKING |
22 |
0.0149 |
| 93 |
ABNORMAL SLEEP-RELATED EVENT |
19 |
0.0144 |
| 94 |
APPLICATION SITE DERMATITIS |
13 |
0.0139 |
| 95 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
55 |
0.0135 |
| 96 |
SUBSTANCE USE DISORDER |
41 |
0.0129 |
| 97 |
REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME |
25 |
0.0127 |
| 98 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
18 |
0.0123 |
| 99 |
AGGRESSION |
600 |
0.0120 |
| 100 |
INTRUSIVE THOUGHTS |
14 |
0.0119 |
| 101 |
REDUCED FACIAL EXPRESSION |
12 |
0.0118 |
| 102 |
ABNORMAL BEHAVIOUR |
463 |
0.0117 |
| 103 |
SUBSTANCE-INDUCED PSYCHOTIC DISORDER |
26 |
0.0116 |
| 104 |
SLEEP PARALYSIS |
17 |
0.0116 |
| 105 |
KOUNIS SYNDROME |
26 |
0.0114 |
| 106 |
PRESCRIBED OVERDOSE |
221 |
0.0114 |
| 107 |
APPLICATION SITE PAPULES |
12 |
0.0113 |
| 108 |
GROWTH RETARDATION |
33 |
0.0112 |
| 109 |
CARDIAC VALVE DISEASE |
64 |
0.0112 |
| 110 |
THERAPEUTIC PRODUCT EFFECT INCREASED |
13 |
0.0112 |
| 111 |
EXPOSURE VIA BREAST MILK |
44 |
0.0110 |
| 112 |
SOMNAMBULISM |
72 |
0.0110 |
| 113 |
SPLENIC INFARCTION |
19 |
0.0109 |
| 114 |
SLEEP APNOEA SYNDROME |
207 |
0.0108 |
| 115 |
VITILIGO |
24 |
0.0102 |
| 116 |
SLEEP TALKING |
17 |
0.0100 |
| 117 |
SEDATION COMPLICATION |
25 |
0.0098 |
| 118 |
BEZOAR |
13 |
0.0094 |
| 119 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
172 |
0.0094 |
| 120 |
HOMICIDAL IDEATION |
38 |
0.0094 |
| 121 |
WISDOM TEETH REMOVAL |
12 |
0.0091 |
| 122 |
SUBSTANCE USE |
14 |
0.0090 |
| 123 |
MECHANICAL VENTILATION |
17 |
0.0089 |
| 124 |
DRUG DOSE OMISSION |
1478 |
0.0089 |
| 125 |
SUICIDAL BEHAVIOUR |
37 |
0.0089 |
| 126 |
CHOREA |
15 |
0.0087 |
| 127 |
DRUG TOLERANCE |
44 |
0.0087 |
| 128 |
CHRONIC FATIGUE SYNDROME |
12 |
0.0086 |
| 129 |
INITIAL INSOMNIA |
87 |
0.0085 |
| 130 |
TRISMUS |
43 |
0.0083 |
| 131 |
MUTISM |
12 |
0.0083 |
| 132 |
SNORING |
31 |
0.0082 |
| 133 |
AFFECT LABILITY |
78 |
0.0081 |
| 134 |
ARTERIOSCLEROSIS CORONARY ARTERY |
53 |
0.0080 |
| 135 |
EXPIRED DRUG ADMINISTERED |
39 |
0.0079 |
| 136 |
BRUXISM |
42 |
0.0078 |
| 137 |
DAYDREAMING |
12 |
0.0078 |
| 138 |
GLUTEN SENSITIVITY |
11 |
0.0077 |
| 139 |
POISONING |
96 |
0.0076 |
| 140 |
SEROTONIN SYNDROME |
146 |
0.0076 |
| 141 |
PRODUCT SUBSTITUTION ISSUE |
437 |
0.0076 |
| 142 |
INCORRECT DOSE ADMINISTERED BY PRODUCT |
12 |
0.0075 |
| 143 |
ENDOTRACHEAL INTUBATION |
21 |
0.0075 |
| 144 |
PRE-ECLAMPSIA |
35 |
0.0074 |
| 145 |
OBSESSIVE-COMPULSIVE DISORDER |
59 |
0.0073 |
| 146 |
TERMINAL INSOMNIA |
13 |
0.0073 |
| 147 |
APPLICATION SITE HAEMORRHAGE |
20 |
0.0073 |
| 148 |
DRUG DIVERSION |
45 |
0.0073 |
| 149 |
MYDRIASIS |
93 |
0.0072 |
| 150 |
MITRAL VALVE PROLAPSE |
12 |
0.0072 |
| 151 |
BEHAVIOUR DISORDER |
39 |
0.0072 |
| 152 |
APPLICATION SITE REACTION |
50 |
0.0071 |
| 153 |
OCULOGYRIC CRISIS |
15 |
0.0070 |
| 154 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
27 |
0.0070 |
| 155 |
SCREAMING |
44 |
0.0069 |
| 156 |
PERSECUTORY DELUSION |
17 |
0.0068 |
| 157 |
OFF LABEL USE |
5959 |
0.0068 |
| 158 |
IMPULSE-CONTROL DISORDER |
14 |
0.0068 |
| 159 |
TONGUE BITING |
14 |
0.0068 |
| 160 |
AUTISM SPECTRUM DISORDER |
37 |
0.0067 |
| 161 |
PRIAPISM |
23 |
0.0067 |
| 162 |
DRUG USE DISORDER |
56 |
0.0067 |
| 163 |
STARING |
16 |
0.0066 |
| 164 |
TORTICOLLIS |
14 |
0.0066 |
| 165 |
ANGER |
222 |
0.0066 |
| 166 |
HANGOVER |
23 |
0.0065 |
| 167 |
DEVICE BREAKAGE |
263 |
0.0065 |
| 168 |
SKIN WOUND |
11 |
0.0065 |
| 169 |
ACUTE PSYCHOSIS |
16 |
0.0065 |
| 170 |
AGITATION |
463 |
0.0063 |
| 171 |
DEVICE DIFFICULT TO USE |
415 |
0.0063 |
| 172 |
IRRITABILITY |
376 |
0.0062 |
| 173 |
HYPERTONIC BLADDER |
18 |
0.0062 |
| 174 |
PHYSICAL ASSAULT |
13 |
0.0062 |
| 175 |
INCREASED APPETITE |
118 |
0.0062 |
| 176 |
SLEEP DEFICIT |
13 |
0.0061 |
| 177 |
PARANOIA |
106 |
0.0061 |
| 178 |
NASAL SEPTUM DEVIATION |
12 |
0.0061 |
| 179 |
DYSTONIA |
115 |
0.0059 |
| 180 |
INTRACRANIAL PRESSURE INCREASED |
33 |
0.0059 |
| 181 |
SOCIAL AVOIDANT BEHAVIOUR |
34 |
0.0059 |
| 182 |
SUSPECTED SUICIDE |
27 |
0.0058 |
| 183 |
MAJOR DEPRESSION |
42 |
0.0057 |
| 184 |
LIVEDO RETICULARIS |
12 |
0.0057 |
| 185 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1157 |
0.0057 |
| 186 |
HALLUCINATION, VISUAL |
118 |
0.0056 |
| 187 |
DRUG DELIVERY SYSTEM ISSUE |
11 |
0.0056 |
| 188 |
HOSTILITY |
14 |
0.0055 |
| 189 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
28 |
0.0055 |
| 190 |
RADIUS FRACTURE |
13 |
0.0054 |
| 191 |
INSULIN RESISTANCE |
11 |
0.0053 |
| 192 |
SUBSTANCE ABUSE |
43 |
0.0053 |
| 193 |
ARTERIOSPASM CORONARY |
21 |
0.0052 |
| 194 |
CRYING |
190 |
0.0052 |
| 195 |
INTENTIONAL SELF-INJURY |
104 |
0.0051 |
| 196 |
DYSKINESIA |
209 |
0.0051 |
| 197 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
15 |
0.0051 |
| 198 |
POST-TRAUMATIC STRESS DISORDER |
34 |
0.0051 |
| 199 |
DRUG ABUSE |
420 |
0.0050 |
| 200 |
HYPERPHAGIA |
20 |
0.0050 |
| 201 |
PSYCHOTIC DISORDER |
148 |
0.0050 |
| 202 |
COMMUNICATION DISORDER |
19 |
0.0050 |
| 203 |
DISSOCIATION |
38 |
0.0050 |
| 204 |
DERMATITIS CONTACT |
56 |
0.0049 |
| 205 |
NYSTAGMUS |
26 |
0.0049 |
| 206 |
THERAPEUTIC RESPONSE CHANGED |
31 |
0.0049 |
| 207 |
INCORRECT PRODUCT STORAGE |
64 |
0.0049 |
| 208 |
BLOOD PRESSURE SYSTOLIC ABNORMAL |
12 |
0.0049 |
| 209 |
GAMBLING DISORDER |
13 |
0.0048 |
| 210 |
SUICIDAL IDEATION |
440 |
0.0048 |
| 211 |
MANIA |
79 |
0.0048 |
| 212 |
APATHY |
70 |
0.0048 |
| 213 |
THERAPY CESSATION |
246 |
0.0048 |
| 214 |
SELF-INJURIOUS IDEATION |
20 |
0.0048 |
| 215 |
BRADYPHRENIA |
31 |
0.0047 |
| 216 |
HALLUCINATION, AUDITORY |
75 |
0.0047 |
| 217 |
BLOOD PRESSURE DIASTOLIC ABNORMAL |
12 |
0.0047 |
| 218 |
FEELING DRUNK |
35 |
0.0047 |
| 219 |
HYPOMANIA |
17 |
0.0046 |
| 220 |
TACHYPHRENIA |
16 |
0.0046 |
| 221 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
21 |
0.0046 |
| 222 |
HALLUCINATIONS, MIXED |
19 |
0.0045 |
| 223 |
DRUG EFFECT DECREASED |
243 |
0.0045 |
| 224 |
CLUMSINESS |
12 |
0.0044 |
| 225 |
CATATONIA |
23 |
0.0044 |
| 226 |
AFFECTIVE DISORDER |
34 |
0.0043 |
| 227 |
RESTLESSNESS |
158 |
0.0043 |
| 228 |
SEDATION |
111 |
0.0042 |
| 229 |
LYME DISEASE |
14 |
0.0042 |
| 230 |
PANIC ATTACK |
153 |
0.0042 |
| 231 |
FEELING JITTERY |
79 |
0.0041 |
| 232 |
THERAPEUTIC RESPONSE UNEXPECTED |
185 |
0.0041 |
| 233 |
AKATHISIA |
56 |
0.0041 |
| 234 |
EUPHORIC MOOD |
42 |
0.0041 |
| 235 |
TOXICITY TO VARIOUS AGENTS |
691 |
0.0041 |
| 236 |
PRODUCT FORMULATION ISSUE |
27 |
0.0041 |
| 237 |
BRADYPNOEA |
11 |
0.0041 |
| 238 |
DELUSION |
63 |
0.0041 |
| 239 |
DEPRESSED MOOD |
213 |
0.0040 |
| 240 |
HYPERREFLEXIA |
14 |
0.0040 |
| 241 |
MOOD SWINGS |
128 |
0.0040 |
| 242 |
EMOTIONAL DISORDER |
123 |
0.0040 |
| 243 |
DEPRESSIVE SYMPTOM |
14 |
0.0040 |
| 244 |
HUNGER |
54 |
0.0039 |
| 245 |
BIPOLAR DISORDER |
42 |
0.0039 |
| 246 |
HYPERPROLACTINAEMIA |
25 |
0.0039 |
| 247 |
TACHYCARDIA |
342 |
0.0038 |
| 248 |
CONGESTIVE CARDIOMYOPATHY |
16 |
0.0038 |
| 249 |
SEASONAL ALLERGY |
54 |
0.0038 |
| 250 |
PARADOXICAL DRUG REACTION |
14 |
0.0038 |
| 251 |
COMA SCALE ABNORMAL |
11 |
0.0038 |
| 252 |
STRESS CARDIOMYOPATHY |
22 |
0.0038 |
| 253 |
WITHDRAWAL SYNDROME |
158 |
0.0038 |
| 254 |
HYPERACUSIS |
14 |
0.0038 |
| 255 |
RESTLESS LEGS SYNDROME |
68 |
0.0037 |
| 256 |
TEARFULNESS |
16 |
0.0037 |
| 257 |
BLOOD SODIUM INCREASED |
10 |
0.0037 |
| 258 |
INTENTIONAL OVERDOSE |
235 |
0.0037 |
| 259 |
DRUG EFFECT LESS THAN EXPECTED |
54 |
0.0036 |
| 260 |
MOOD ALTERED |
99 |
0.0036 |
| 261 |
DECREASED INTEREST |
21 |
0.0036 |
| 262 |
PERSONALITY CHANGE |
33 |
0.0035 |
| 263 |
PETIT MAL EPILEPSY |
18 |
0.0035 |
| 264 |
SUICIDE ATTEMPT |
213 |
0.0035 |
| 265 |
DECREASED APPETITE |
815 |
0.0035 |
| 266 |
SALIVARY HYPERSECRETION |
35 |
0.0035 |
| 267 |
PANIC REACTION |
25 |
0.0035 |
| 268 |
MITRAL VALVE INCOMPETENCE |
39 |
0.0034 |
| 269 |
DYSPHEMIA |
15 |
0.0034 |
| 270 |
COMPLETED SUICIDE |
285 |
0.0034 |
| 271 |
EYE MOVEMENT DISORDER |
23 |
0.0034 |
| 272 |
PRODUCT RESIDUE PRESENT |
18 |
0.0033 |
| 273 |
PRODUCT AVAILABILITY ISSUE |
76 |
0.0033 |
| 274 |
SLEEP TERROR |
14 |
0.0033 |
| 275 |
TREATMENT NONCOMPLIANCE |
181 |
0.0033 |
| 276 |
CRANIOCEREBRAL INJURY |
10 |
0.0033 |
| 277 |
MUSCLE TWITCHING |
75 |
0.0033 |
| 278 |
BRAIN DEATH |
10 |
0.0032 |
| 279 |
UNRESPONSIVE TO STIMULI |
83 |
0.0032 |
| 280 |
DRUG LEVEL INCREASED |
53 |
0.0032 |
| 281 |
STATUS EPILEPTICUS |
36 |
0.0032 |
| 282 |
BODY TEMPERATURE INCREASED |
65 |
0.0032 |
| 283 |
AUTOIMMUNE THYROIDITIS |
12 |
0.0032 |
| 284 |
DYSPHORIA |
16 |
0.0032 |
| 285 |
HYPERTHERMIA |
24 |
0.0031 |
| 286 |
HYPERTONIA |
18 |
0.0031 |
| 287 |
SURGERY |
184 |
0.0031 |
| 288 |
DEVICE PHYSICAL PROPERTY ISSUE |
24 |
0.0031 |
| 289 |
MUSCLE CONTRACTIONS INVOLUNTARY |
11 |
0.0031 |
| 290 |
CONCUSSION |
24 |
0.0031 |
| 291 |
SINUS TACHYCARDIA |
44 |
0.0031 |
| 292 |
STREPTOCOCCAL INFECTION |
17 |
0.0031 |
| 293 |
MYOCARDITIS |
35 |
0.0031 |
| 294 |
ANXIETY |
868 |
0.0030 |
| 295 |
BUNDLE BRANCH BLOCK RIGHT |
14 |
0.0030 |
| 296 |
SHOULDER OPERATION |
13 |
0.0030 |
| 297 |
GENERALISED TONIC-CLONIC SEIZURE |
50 |
0.0030 |
| 298 |
APPETITE DISORDER |
20 |
0.0030 |
| 299 |
TACHYPNOEA |
41 |
0.0030 |
| 300 |
REBOUND EFFECT |
34 |
0.0030 |
| 301 |
FOOD ALLERGY |
23 |
0.0030 |
| 302 |
ELECTROCARDIOGRAM QT PROLONGED |
107 |
0.0030 |
| 303 |
VITAMIN B12 DEFICIENCY |
12 |
0.0030 |
| 304 |
RESPIRATORY DEPRESSION |
36 |
0.0029 |
| 305 |
INCOHERENT |
19 |
0.0029 |
| 306 |
ABNORMAL LOSS OF WEIGHT |
20 |
0.0029 |
| 307 |
ANAL INCONTINENCE |
26 |
0.0029 |
| 308 |
VITAMIN D DEFICIENCY |
28 |
0.0029 |
| 309 |
SOMNOLENCE |
574 |
0.0028 |
| 310 |
BRAIN OEDEMA |
36 |
0.0028 |
| 311 |
DEPRESSION |
641 |
0.0028 |
| 312 |
BLOOD PRESSURE DIASTOLIC INCREASED |
13 |
0.0028 |
| 313 |
INSOMNIA |
746 |
0.0028 |
| 314 |
OVERWEIGHT |
15 |
0.0028 |
| 315 |
PERFORMANCE STATUS DECREASED |
13 |
0.0028 |
| 316 |
CARDIO-RESPIRATORY ARREST |
115 |
0.0027 |
| 317 |
MIDDLE INSOMNIA |
51 |
0.0027 |
| 318 |
FORMICATION |
19 |
0.0027 |
| 319 |
RECALLED PRODUCT ADMINISTERED |
26 |
0.0027 |
| 320 |
IRON DEFICIENCY |
12 |
0.0027 |
| 321 |
DRUG SCREEN POSITIVE |
21 |
0.0027 |
| 322 |
THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION |
11 |
0.0026 |
| 323 |
POOR QUALITY SLEEP |
57 |
0.0026 |
| 324 |
URINARY INCONTINENCE |
78 |
0.0026 |
| 325 |
INTENTIONAL DOSE OMISSION |
74 |
0.0026 |
| 326 |
HYPERVENTILATION |
15 |
0.0026 |
| 327 |
FOOT FRACTURE |
49 |
0.0026 |
| 328 |
COORDINATION ABNORMAL |
36 |
0.0026 |
| 329 |
ROSACEA |
12 |
0.0026 |
| 330 |
HALLUCINATION |
194 |
0.0026 |
| 331 |
APNOEA |
20 |
0.0026 |
| 332 |
SLEEP DISORDER |
181 |
0.0026 |
| 333 |
SLUGGISHNESS |
26 |
0.0025 |
| 334 |
ENDOMETRIOSIS |
12 |
0.0025 |
| 335 |
OBESITY |
40 |
0.0025 |
| 336 |
DRUG INTERACTION |
397 |
0.0025 |
| 337 |
THERAPY PARTIAL RESPONDER |
39 |
0.0025 |
| 338 |
THIRST |
44 |
0.0025 |
| 339 |
ANKLE FRACTURE |
38 |
0.0025 |
| 340 |
HYSTERECTOMY |
21 |
0.0024 |
| 341 |
ELECTROCARDIOGRAM ABNORMAL |
19 |
0.0024 |
| 342 |
DEVICE ISSUE |
217 |
0.0024 |
| 343 |
MULTIPLE DRUG OVERDOSE |
12 |
0.0024 |
| 344 |
METABOLIC DISORDER |
14 |
0.0024 |
| 345 |
NIGHTMARE |
83 |
0.0024 |
| 346 |
NOCTURIA |
29 |
0.0024 |
| 347 |
GRAND MAL CONVULSION |
22 |
0.0024 |
| 348 |
INTENTIONAL PRODUCT MISUSE |
208 |
0.0024 |
| 349 |
NEUROLEPTIC MALIGNANT SYNDROME |
28 |
0.0024 |
| 350 |
HYPOKINESIA |
34 |
0.0023 |
| 351 |
SKIN ABRASION |
11 |
0.0023 |
| 352 |
INTENTIONAL PRODUCT USE ISSUE |
202 |
0.0023 |
| 353 |
PARTIAL SEIZURES |
12 |
0.0023 |
| 354 |
ATAXIA |
27 |
0.0023 |
| 355 |
DRUG LEVEL DECREASED |
23 |
0.0023 |
| 356 |
COELIAC DISEASE |
22 |
0.0022 |
| 357 |
KNEE OPERATION |
22 |
0.0022 |
| 358 |
FRUSTRATION TOLERANCE DECREASED |
18 |
0.0022 |
| 359 |
INSURANCE ISSUE |
34 |
0.0022 |
| 360 |
BLEPHAROSPASM |
14 |
0.0022 |
| 361 |
DRUG INEFFECTIVE |
2929 |
0.0022 |
| 362 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
12 |
0.0022 |
| 363 |
IMPAIRED GASTRIC EMPTYING |
30 |
0.0022 |
| 364 |
THINKING ABNORMAL |
41 |
0.0022 |
| 365 |
HYPERAMMONAEMIA |
11 |
0.0022 |
| 366 |
IMPAIRED DRIVING ABILITY |
25 |
0.0022 |
| 367 |
PSYCHIATRIC SYMPTOM |
16 |
0.0022 |
| 368 |
TARDIVE DYSKINESIA |
61 |
0.0022 |
| 369 |
MENTAL IMPAIRMENT |
52 |
0.0021 |
| 370 |
FEELING OF DESPAIR |
10 |
0.0021 |
| 371 |
EXTRAPYRAMIDAL DISORDER |
53 |
0.0021 |
| 372 |
APLASTIC ANAEMIA |
11 |
0.0021 |
| 373 |
MIGRAINE |
201 |
0.0021 |
| 374 |
BRAIN FOG |
33 |
0.0021 |
| 375 |
LETHARGY |
121 |
0.0021 |
| 376 |
HYPERHIDROSIS |
270 |
0.0021 |
| 377 |
HYPERSOMNIA |
60 |
0.0021 |
| 378 |
MUSCLE RIGIDITY |
25 |
0.0021 |
| 379 |
IMPAIRED QUALITY OF LIFE |
30 |
0.0021 |
| 380 |
OVERDOSE |
447 |
0.0021 |
| 381 |
MOTOR DYSFUNCTION |
21 |
0.0021 |
| 382 |
ECCHYMOSIS |
14 |
0.0020 |
| 383 |
ENERGY INCREASED |
12 |
0.0020 |
| 384 |
RESPIRATION ABNORMAL |
14 |
0.0020 |
| 385 |
GLUCOSE TOLERANCE IMPAIRED |
12 |
0.0020 |
| 386 |
BACK INJURY |
22 |
0.0020 |
| 387 |
MENTAL DISORDER |
88 |
0.0020 |
| 388 |
FOOT OPERATION |
10 |
0.0020 |
| 389 |
CHOLECYSTECTOMY |
23 |
0.0020 |
| 390 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
79 |
0.0020 |
| 391 |
MIOSIS |
16 |
0.0020 |
| 392 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
89 |
0.0020 |
| 393 |
CYSTIC FIBROSIS |
11 |
0.0020 |
| 394 |
SUPRAVENTRICULAR TACHYCARDIA |
19 |
0.0020 |
| 395 |
FIBROMYALGIA |
48 |
0.0020 |
| 396 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
12 |
0.0020 |
| 397 |
PRODUCT SUPPLY ISSUE |
14 |
0.0020 |
| 398 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
14 |
0.0020 |
| 399 |
CARDIAC FAILURE ACUTE |
13 |
0.0019 |
| 400 |
HYPOTHYROIDISM |
62 |
0.0019 |
| 401 |
ALTERED STATE OF CONSCIOUSNESS |
42 |
0.0019 |
| 402 |
SCOLIOSIS |
12 |
0.0019 |
| 403 |
THERAPEUTIC RESPONSE SHORTENED |
64 |
0.0019 |
| 404 |
TOOTH EXTRACTION |
24 |
0.0019 |
| 405 |
LIGAMENT SPRAIN |
19 |
0.0019 |
| 406 |
FOOD CRAVING |
10 |
0.0019 |
| 407 |
HYPERTENSION |
402 |
0.0019 |
| 408 |
NERVOUSNESS |
99 |
0.0019 |
| 409 |
TREMOR |
314 |
0.0019 |
| 410 |
HEAVY MENSTRUAL BLEEDING |
17 |
0.0019 |
| 411 |
CIRCULATORY COLLAPSE |
32 |
0.0019 |
| 412 |
EATING DISORDER |
40 |
0.0019 |
| 413 |
ACCIDENTAL EXPOSURE TO PRODUCT |
193 |
0.0019 |
| 414 |
GALACTORRHOEA |
12 |
0.0019 |
| 415 |
SPINAL OPERATION |
23 |
0.0019 |
| 416 |
FEAR |
50 |
0.0019 |
| 417 |
ABNORMAL DREAMS |
51 |
0.0018 |
| 418 |
SKIN REACTION |
26 |
0.0018 |
| 419 |
PNEUMONIA ASPIRATION |
46 |
0.0018 |
| 420 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
53 |
0.0018 |
| 421 |
WEIGHT DECREASED |
513 |
0.0018 |
| 422 |
INTERVERTEBRAL DISC DEGENERATION |
17 |
0.0018 |
| 423 |
PRODUCT PHYSICAL ISSUE |
37 |
0.0018 |
| 424 |
CONDITION AGGRAVATED |
557 |
0.0018 |
| 425 |
PALPITATIONS |
214 |
0.0018 |
| 426 |
PERIPHERAL COLDNESS |
25 |
0.0018 |
| 427 |
DISABILITY |
36 |
0.0018 |
| 428 |
SCHIZOPHRENIA |
22 |
0.0018 |
| 429 |
DENTAL CARIES |
20 |
0.0018 |
| 430 |
FEELING ABNORMAL |
432 |
0.0018 |
| 431 |
INCONTINENCE |
19 |
0.0018 |
| 432 |
INTERVERTEBRAL DISC PROTRUSION |
39 |
0.0018 |
| 433 |
UTERINE LEIOMYOMA |
13 |
0.0018 |
| 434 |
PRODUCT USE COMPLAINT |
28 |
0.0018 |
| 435 |
HEART RATE INCREASED |
175 |
0.0018 |
| 436 |
PRODUCT PRESCRIBING ERROR |
42 |
0.0018 |
| 437 |
LARGE INTESTINE POLYP |
12 |
0.0017 |
| 438 |
HEPATIC STEATOSIS |
32 |
0.0017 |
| 439 |
SEIZURE |
198 |
0.0017 |
| 440 |
COGNITIVE DISORDER |
80 |
0.0017 |
| 441 |
CLOSTRIDIUM DIFFICILE COLITIS |
18 |
0.0017 |
| 442 |
MEMORY IMPAIRMENT |
233 |
0.0017 |
| 443 |
BRAIN INJURY |
17 |
0.0017 |
| 444 |
ORAL HERPES |
33 |
0.0017 |
| 445 |
RESPIRATORY RATE INCREASED |
15 |
0.0017 |
| 446 |
GYNAECOMASTIA |
52 |
0.0017 |
| 447 |
MYOCLONUS |
20 |
0.0017 |
| 448 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
119 |
0.0017 |
| 449 |
UNEVALUABLE EVENT |
126 |
0.0017 |
| 450 |
MULTIPLE ALLERGIES |
13 |
0.0017 |
| 451 |
SPEECH DISORDER |
86 |
0.0016 |
| 452 |
NEPHROLITHIASIS |
75 |
0.0016 |
| 453 |
RESPIRATORY ARREST |
45 |
0.0016 |
| 454 |
SENSORY DISTURBANCE |
26 |
0.0016 |
| 455 |
SCRATCH |
17 |
0.0016 |
| 456 |
JOINT DISLOCATION |
17 |
0.0016 |
| 457 |
ORTHOSTATIC HYPOTENSION |
28 |
0.0016 |
| 458 |
MUSCLE TIGHTNESS |
26 |
0.0016 |
| 459 |
FOETAL EXPOSURE DURING PREGNANCY |
130 |
0.0016 |
| 460 |
RETCHING |
34 |
0.0016 |
| 461 |
CYANOSIS |
25 |
0.0016 |
| 462 |
NIGHT SWEATS |
51 |
0.0016 |
| 463 |
MICTURITION URGENCY |
18 |
0.0016 |
| 464 |
DECREASED ACTIVITY |
17 |
0.0016 |
| 465 |
GASTROOESOPHAGEAL REFLUX DISEASE |
126 |
0.0016 |
| 466 |
NEURALGIA |
38 |
0.0016 |
| 467 |
LOSS OF LIBIDO |
14 |
0.0016 |
| 468 |
DRY MOUTH |
125 |
0.0015 |
| 469 |
DRUG-INDUCED LIVER INJURY |
48 |
0.0015 |
| 470 |
CONFUSIONAL STATE |
247 |
0.0015 |
| 471 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
33 |
0.0015 |
| 472 |
AMNESIA |
99 |
0.0015 |
| 473 |
VITAMIN D DECREASED |
13 |
0.0015 |
| 474 |
PHOTOSENSITIVITY REACTION |
25 |
0.0015 |
| 475 |
SUDDEN DEATH |
16 |
0.0015 |
| 476 |
BLADDER DISORDER |
15 |
0.0015 |
| 477 |
INABILITY TO AFFORD MEDICATION |
15 |
0.0015 |
| 478 |
PHARMACEUTICAL PRODUCT COMPLAINT |
39 |
0.0015 |
| 479 |
BLOOD PRESSURE INCREASED |
229 |
0.0015 |
| 480 |
ACUTE MYOCARDIAL INFARCTION |
44 |
0.0015 |
| 481 |
BREAST MASS |
10 |
0.0015 |
| 482 |
LYMPHOPENIA |
21 |
0.0015 |
| 483 |
INTENTIONAL DRUG MISUSE |
31 |
0.0015 |
| 484 |
MENTAL STATUS CHANGES |
41 |
0.0015 |
| 485 |
POST PROCEDURAL INFECTION |
12 |
0.0015 |
| 486 |
WEIGHT INCREASED |
330 |
0.0015 |
| 487 |
LIMB INJURY |
40 |
0.0015 |
| 488 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
25 |
0.0015 |
| 489 |
RASH GENERALISED |
38 |
0.0015 |
| 490 |
MUSCULOSKELETAL DISCOMFORT |
25 |
0.0015 |
| 491 |
SINUS BRADYCARDIA |
14 |
0.0014 |
| 492 |
SINUSITIS |
148 |
0.0014 |
| 493 |
STEVENS-JOHNSON SYNDROME |
32 |
0.0014 |
| 494 |
AUTOIMMUNE DISORDER |
14 |
0.0014 |
| 495 |
MALNUTRITION |
16 |
0.0014 |
| 496 |
SKIN IRRITATION |
65 |
0.0014 |
| 497 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
68 |
0.0014 |
| 498 |
LOSS OF CONSCIOUSNESS |
181 |
0.0014 |
| 499 |
NERVE COMPRESSION |
13 |
0.0014 |
| 500 |
MOVEMENT DISORDER |
45 |
0.0014 |
| 501 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
24 |
0.0014 |
| 502 |
CARDIAC ARREST |
115 |
0.0014 |
| 503 |
TREATMENT FAILURE |
115 |
0.0014 |
| 504 |
GASTROENTERITIS VIRAL |
25 |
0.0014 |
| 505 |
MUSCLE SPASTICITY |
17 |
0.0014 |
| 506 |
SKIN LACERATION |
15 |
0.0014 |
| 507 |
PRODUCT DISPENSING ERROR |
30 |
0.0014 |
| 508 |
DRY THROAT |
14 |
0.0014 |
| 509 |
EXPOSURE DURING PREGNANCY |
85 |
0.0014 |
| 510 |
SEXUAL DYSFUNCTION |
16 |
0.0014 |
| 511 |
ERECTILE DYSFUNCTION |
35 |
0.0014 |
| 512 |
ROAD TRAFFIC ACCIDENT |
57 |
0.0014 |
| 513 |
TOOTH FRACTURE |
15 |
0.0014 |
| 514 |
PRODUCT COMMUNICATION ISSUE |
12 |
0.0014 |
| 515 |
THERAPY NON-RESPONDER |
61 |
0.0014 |
| 516 |
IMPAIRED WORK ABILITY |
29 |
0.0014 |
| 517 |
EXPIRED PRODUCT ADMINISTERED |
45 |
0.0014 |
| 518 |
POOR VENOUS ACCESS |
14 |
0.0014 |
| 519 |
ARTHROPOD BITE |
10 |
0.0013 |
| 520 |
HEADACHE |
846 |
0.0013 |
| 521 |
NERVE INJURY |
15 |
0.0013 |
| 522 |
ASPHYXIA |
11 |
0.0013 |
| 523 |
COMA |
64 |
0.0013 |
| 524 |
HYPERAESTHESIA |
11 |
0.0013 |
| 525 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
73 |
0.0013 |
| 526 |
PHARYNGEAL SWELLING |
13 |
0.0013 |
| 527 |
THERAPY CHANGE |
13 |
0.0013 |
| 528 |
LIP DRY |
12 |
0.0013 |
| 529 |
THERAPEUTIC RESPONSE DECREASED |
80 |
0.0013 |
| 530 |
URINARY RETENTION |
44 |
0.0013 |
| 531 |
EAR INFECTION |
35 |
0.0013 |
| 532 |
EXOSTOSIS |
12 |
0.0013 |
| 533 |
ATRIAL SEPTAL DEFECT |
11 |
0.0013 |
| 534 |
DISORIENTATION |
52 |
0.0013 |
| 535 |
SENSATION OF FOREIGN BODY |
11 |
0.0013 |
| 536 |
HEAD DISCOMFORT |
23 |
0.0013 |
| 537 |
BACK DISORDER |
21 |
0.0013 |
| 538 |
FACIAL PARALYSIS |
11 |
0.0013 |
| 539 |
PALLOR |
35 |
0.0013 |
| 540 |
APPENDICITIS |
12 |
0.0013 |
| 541 |
FEEDING DISORDER |
26 |
0.0013 |
| 542 |
EPILEPSY |
39 |
0.0013 |
| 543 |
PSYCHOLOGICAL TRAUMA |
11 |
0.0013 |
| 544 |
DELIRIUM |
44 |
0.0013 |
| 545 |
QUALITY OF LIFE DECREASED |
17 |
0.0013 |
| 546 |
BLOOD IRON DECREASED |
15 |
0.0013 |
| 547 |
RIB FRACTURE |
26 |
0.0013 |
| 548 |
ILLNESS |
130 |
0.0013 |
| 549 |
APHASIA |
38 |
0.0013 |
| 550 |
SINUS CONGESTION |
17 |
0.0013 |
| 551 |
BLOOD PRESSURE ABNORMAL |
25 |
0.0013 |
| 552 |
MULTIPLE SCLEROSIS RELAPSE |
86 |
0.0013 |
| 553 |
SCIATICA |
20 |
0.0013 |
| 554 |
CARDIOGENIC SHOCK |
18 |
0.0013 |
| 555 |
SPINAL OSTEOARTHRITIS |
11 |
0.0013 |
| 556 |
POLLAKIURIA |
52 |
0.0012 |
| 557 |
ROTATOR CUFF SYNDROME |
16 |
0.0012 |
| 558 |
LYMPHOCYTE COUNT DECREASED |
22 |
0.0012 |
| 559 |
PRODUCT DOSE OMISSION |
81 |
0.0012 |
| 560 |
DEVICE MECHANICAL ISSUE |
17 |
0.0012 |
| 561 |
KIDNEY INFECTION |
24 |
0.0012 |
| 562 |
RHABDOMYOLYSIS |
51 |
0.0012 |
| 563 |
EYE DISORDER |
40 |
0.0012 |
| 564 |
ABNORMAL WEIGHT GAIN |
15 |
0.0012 |
| 565 |
TOOTH DISORDER |
27 |
0.0012 |
| 566 |
CARPAL TUNNEL SYNDROME |
17 |
0.0012 |
| 567 |
PULMONARY CONGESTION |
16 |
0.0012 |
| 568 |
IRRITABLE BOWEL SYNDROME |
26 |
0.0012 |
| 569 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
24 |
0.0012 |
| 570 |
DEVICE DEFECTIVE |
21 |
0.0012 |
| 571 |
SARS-COV-2 TEST POSITIVE |
16 |
0.0012 |
| 572 |
CYST |
15 |
0.0012 |
| 573 |
DRUG RESISTANCE |
31 |
0.0012 |
| 574 |
ARRHYTHMIA |
57 |
0.0012 |
| 575 |
DRUG WITHDRAWAL SYNDROME |
105 |
0.0012 |
| 576 |
BALANCE DISORDER |
103 |
0.0012 |
| 577 |
BRONCHOSPASM |
17 |
0.0012 |
| 578 |
ECONOMIC PROBLEM |
18 |
0.0012 |
| 579 |
ASPIRATION |
13 |
0.0012 |
| 580 |
HEPATIC ENCEPHALOPATHY |
11 |
0.0012 |
| 581 |
DRUG DISPENSING ERROR |
18 |
0.0012 |
| 582 |
TINNITUS |
54 |
0.0012 |
| 583 |
NEUTROPHIL COUNT INCREASED |
12 |
0.0012 |
| 584 |
CONVULSION |
67 |
0.0012 |
| 585 |
ACUTE HEPATIC FAILURE |
16 |
0.0012 |
| 586 |
PHOTOPHOBIA |
22 |
0.0012 |
| 587 |
DEVICE RELATED INFECTION |
18 |
0.0012 |
| 588 |
EAR DISCOMFORT |
12 |
0.0012 |
| 589 |
THYROID DISORDER |
18 |
0.0012 |
| 590 |
CENTRAL NERVOUS SYSTEM LESION |
16 |
0.0012 |
| 591 |
BLOOD POTASSIUM DECREASED |
35 |
0.0012 |
| 592 |
DISCOMFORT |
71 |
0.0012 |
| 593 |
SINUS DISORDER |
23 |
0.0012 |
| 594 |
POISONING DELIBERATE |
11 |
0.0012 |
| 595 |
PRODUCT PACKAGING ISSUE |
11 |
0.0012 |
| 596 |
ABDOMINAL PAIN UPPER |
238 |
0.0012 |
| 597 |
VENTRICULAR EXTRASYSTOLES |
12 |
0.0012 |
| 598 |
VENTRICULAR TACHYCARDIA |
19 |
0.0011 |
| 599 |
BRADYCARDIA |
61 |
0.0011 |
| 600 |
PETECHIAE |
12 |
0.0011 |
| 601 |
SKIN HAEMORRHAGE |
17 |
0.0011 |
| 602 |
THROAT TIGHTNESS |
31 |
0.0011 |
| 603 |
PRODUCT ODOUR ABNORMAL |
12 |
0.0011 |
| 604 |
DRY EYE |
57 |
0.0011 |
| 605 |
KNEE ARTHROPLASTY |
24 |
0.0011 |
| 606 |
TOOTH INFECTION |
15 |
0.0011 |
| 607 |
HYPOPHAGIA |
29 |
0.0011 |
| 608 |
VOMITING |
530 |
0.0011 |
| 609 |
RESPIRATORY DISTRESS |
31 |
0.0011 |
| 610 |
HEPATOMEGALY |
11 |
0.0011 |
| 611 |
MUSCLE SPASMS |
205 |
0.0011 |
| 612 |
FATIGUE |
866 |
0.0011 |
| 613 |
SCAR |
19 |
0.0011 |
| 614 |
MULTIPLE SCLEROSIS |
53 |
0.0011 |
| 615 |
DRUG DEPENDENCE |
178 |
0.0011 |
| 616 |
HEAD INJURY |
35 |
0.0011 |
| 617 |
GASTROINTESTINAL DISORDER |
99 |
0.0011 |
| 618 |
ANHEDONIA |
29 |
0.0011 |
| 619 |
HYPERSENSITIVITY |
204 |
0.0011 |
| 620 |
PRODUCT DOSE OMISSION ISSUE |
323 |
0.0011 |
| 621 |
MEDICATION ERROR |
61 |
0.0011 |
| 622 |
POOR QUALITY DEVICE USED |
11 |
0.0011 |
| 623 |
DIZZINESS |
546 |
0.0011 |
| 624 |
CHOLESTASIS |
21 |
0.0011 |
| 625 |
PERITONITIS BACTERIAL |
11 |
0.0011 |
| 626 |
CONTRAINDICATED PRODUCT ADMINISTERED |
33 |
0.0011 |
| 627 |
DYSARTHRIA |
41 |
0.0011 |
| 628 |
VENTRICULAR FIBRILLATION |
12 |
0.0011 |
| 629 |
DIPLOPIA |
28 |
0.0011 |
| 630 |
VISION BLURRED |
148 |
0.0011 |
| 631 |
DRUG INTOLERANCE |
104 |
0.0011 |
| 632 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
19 |
0.0011 |
| 633 |
PANCREATITIS ACUTE |
24 |
0.0011 |
| 634 |
FLANK PAIN |
10 |
0.0011 |
| 635 |
PRURITUS GENERALISED |
23 |
0.0011 |
| 636 |
METABOLIC ACIDOSIS |
34 |
0.0011 |
| 637 |
NECK PAIN |
59 |
0.0011 |
| 638 |
FALL |
351 |
0.0011 |
| 639 |
NAUSEA |
832 |
0.0011 |
| 640 |
PULMONARY OEDEMA |
47 |
0.0010 |
| 641 |
HYPOAESTHESIA |
157 |
0.0010 |
| 642 |
MUSCULAR WEAKNESS |
119 |
0.0010 |
| 643 |
WHITE BLOOD CELL COUNT INCREASED |
40 |
0.0010 |
| 644 |
PARAESTHESIA |
164 |
0.0010 |
| 645 |
LOWER LIMB FRACTURE |
20 |
0.0010 |
| 646 |
TENDONITIS |
16 |
0.0010 |
| 647 |
DIZZINESS POSTURAL |
10 |
0.0010 |
| 648 |
BLOOD CHOLESTEROL INCREASED |
48 |
0.0010 |
| 649 |
DEVICE USE ISSUE |
18 |
0.0010 |
| 650 |
FEELING HOT |
63 |
0.0010 |
| 651 |
HYPOXIA |
36 |
0.0010 |
| 652 |
ABDOMINAL DISCOMFORT |
170 |
0.0010 |
| 653 |
GAIT DISTURBANCE |
193 |
0.0010 |
| 654 |
IMMUNODEFICIENCY |
15 |
0.0010 |
| 655 |
FEELING COLD |
28 |
0.0010 |
| 656 |
ACCIDENT |
12 |
0.0010 |
| 657 |
HIATUS HERNIA |
13 |
0.0010 |
| 658 |
APHONIA |
14 |
0.0010 |
| 659 |
RESPIRATORY DISORDER |
30 |
0.0010 |
| 660 |
DEAFNESS |
26 |
0.0010 |
| 661 |
ECZEMA |
52 |
0.0010 |
| 662 |
FOOT DEFORMITY |
11 |
0.0010 |
| 663 |
CHEST PAIN |
183 |
0.0010 |
| 664 |
END STAGE RENAL DISEASE |
18 |
0.0010 |
| 665 |
BRONCHITIS |
73 |
0.0010 |
| 666 |
OCULAR DISCOMFORT |
11 |
0.0010 |
| 667 |
FLUSHING |
99 |
0.0010 |
| 668 |
HEART RATE DECREASED |
34 |
0.0010 |
| 669 |
NASOPHARYNGITIS |
178 |
0.0010 |
| 670 |
PRODUCT PRESCRIBING ISSUE |
21 |
0.0010 |
| 671 |
PRODUCT TASTE ABNORMAL |
13 |
0.0010 |
| 672 |
GASTROENTERITIS |
14 |
0.0010 |
| 673 |
GAIT INABILITY |
32 |
0.0010 |
| 674 |
PRODUCT DOSE OMISSION IN ERROR |
27 |
0.0010 |
| 675 |
PRODUCT USE ISSUE |
179 |
0.0010 |
| 676 |
ELECTROLYTE IMBALANCE |
11 |
0.0009 |
| 677 |
LEUKOCYTOSIS |
17 |
0.0009 |
| 678 |
GLOSSODYNIA |
21 |
0.0009 |
| 679 |
ORAL PAIN |
21 |
0.0009 |
| 680 |
ASTHMA |
106 |
0.0009 |
| 681 |
CHRONIC KIDNEY DISEASE |
71 |
0.0009 |
| 682 |
INFUSION SITE PAIN |
12 |
0.0009 |
| 683 |
HYPOAESTHESIA ORAL |
14 |
0.0009 |
| 684 |
HEPATIC ENZYME INCREASED |
63 |
0.0009 |
| 685 |
CHOKING |
18 |
0.0009 |
| 686 |
OSTEOPENIA |
14 |
0.0009 |
| 687 |
HYPERLIPIDAEMIA |
11 |
0.0009 |
| 688 |
OSTEOARTHRITIS |
39 |
0.0009 |
| 689 |
VERTIGO |
56 |
0.0009 |
| 690 |
LIMB DISCOMFORT |
28 |
0.0009 |
| 691 |
PRESYNCOPE |
22 |
0.0009 |
| 692 |
MUSCULOSKELETAL CHEST PAIN |
14 |
0.0009 |
| 693 |
UPPER LIMB FRACTURE |
18 |
0.0009 |
| 694 |
GASTRIC DISORDER |
31 |
0.0009 |
| 695 |
NO THERAPEUTIC RESPONSE |
11 |
0.0009 |
| 696 |
ACCIDENTAL OVERDOSE |
33 |
0.0009 |
| 697 |
SWOLLEN TONGUE |
28 |
0.0009 |
| 698 |
DERMATITIS ATOPIC |
47 |
0.0009 |
| 699 |
NASAL CONGESTION |
52 |
0.0009 |
| 700 |
DYSPEPSIA |
87 |
0.0009 |
| 701 |
TOOTHACHE |
16 |
0.0009 |
| 702 |
URTICARIA |
148 |
0.0009 |
| 703 |
ADVERSE DRUG REACTION |
79 |
0.0009 |
| 704 |
HERNIA |
17 |
0.0009 |
| 705 |
INCORRECT DOSE ADMINISTERED |
200 |
0.0009 |
| 706 |
VIRAL INFECTION |
29 |
0.0009 |
| 707 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
31 |
0.0009 |
| 708 |
DISEASE RECURRENCE |
41 |
0.0009 |
| 709 |
CAESAREAN SECTION |
10 |
0.0009 |
| 710 |
BACTERIAL INFECTION |
16 |
0.0009 |
| 711 |
UPPER RESPIRATORY TRACT INFECTION |
39 |
0.0008 |
| 712 |
JOINT INJURY |
18 |
0.0008 |
| 713 |
LIP SWELLING |
28 |
0.0008 |
| 714 |
CATARACT |
50 |
0.0008 |
| 715 |
COVID-19 |
147 |
0.0008 |
| 716 |
ANGINA PECTORIS |
24 |
0.0008 |
| 717 |
BLOOD UREA INCREASED |
14 |
0.0008 |
| 718 |
BLOOD PRESSURE FLUCTUATION |
20 |
0.0008 |
| 719 |
CONSTIPATION |
181 |
0.0008 |
| 720 |
DYSMENORRHOEA |
11 |
0.0008 |
| 721 |
ASPARTATE AMINOTRANSFERASE INCREASED |
44 |
0.0008 |
| 722 |
SKIN DISCOLOURATION |
38 |
0.0008 |
| 723 |
CLOSTRIDIUM DIFFICILE INFECTION |
18 |
0.0008 |
| 724 |
BURSITIS |
10 |
0.0008 |
| 725 |
ADRENAL INSUFFICIENCY |
10 |
0.0008 |
| 726 |
MALIGNANT MELANOMA |
11 |
0.0008 |
| 727 |
RASH |
356 |
0.0008 |
| 728 |
MALAISE |
358 |
0.0008 |
| 729 |
PULMONARY HYPERTENSION |
17 |
0.0008 |
| 730 |
ABSCESS |
13 |
0.0008 |
| 731 |
DERMATITIS |
17 |
0.0008 |
| 732 |
DYSPHAGIA |
77 |
0.0008 |
| 733 |
SNEEZING |
18 |
0.0008 |
| 734 |
THROAT IRRITATION |
36 |
0.0008 |
| 735 |
VISUAL IMPAIRMENT |
99 |
0.0008 |
| 736 |
AMENORRHOEA |
14 |
0.0008 |
| 737 |
DERMATITIS ALLERGIC |
10 |
0.0008 |
| 738 |
COLD SWEAT |
14 |
0.0008 |
| 739 |
SYNCOPE |
79 |
0.0008 |
| 740 |
INFLUENZA |
88 |
0.0008 |
| 741 |
ALANINE AMINOTRANSFERASE INCREASED |
48 |
0.0008 |
| 742 |
CONTUSION |
75 |
0.0008 |
| 743 |
PRODUCT PREPARATION ERROR |
16 |
0.0008 |
| 744 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
55 |
0.0008 |
| 745 |
BLOOD PRESSURE SYSTOLIC INCREASED |
15 |
0.0008 |
| 746 |
HAEMORRHOIDS |
15 |
0.0008 |
| 747 |
NERVOUS SYSTEM DISORDER |
24 |
0.0008 |
| 748 |
ANGIOEDEMA |
34 |
0.0008 |
| 749 |
PARALYSIS |
11 |
0.0008 |
| 750 |
PRURITUS |
293 |
0.0008 |
| 751 |
LACRIMATION INCREASED |
23 |
0.0008 |
| 752 |
ANAPHYLACTIC REACTION |
42 |
0.0008 |
| 753 |
RHINORRHOEA |
49 |
0.0008 |
| 754 |
RASH ERYTHEMATOUS |
36 |
0.0008 |
| 755 |
HEART RATE IRREGULAR |
17 |
0.0008 |
| 756 |
SKIN DISORDER |
25 |
0.0007 |
| 757 |
HAEMATEMESIS |
19 |
0.0007 |
| 758 |
OROPHARYNGEAL PAIN |
69 |
0.0007 |
| 759 |
CHEST DISCOMFORT |
76 |
0.0007 |
| 760 |
NEUROPATHY PERIPHERAL |
70 |
0.0007 |
| 761 |
EMOTIONAL DISTRESS |
89 |
0.0007 |
| 762 |
DEHYDRATION |
98 |
0.0007 |
| 763 |
CORONARY ARTERY OCCLUSION |
10 |
0.0007 |
| 764 |
SKIN LESION |
20 |
0.0007 |
| 765 |
POST PROCEDURAL COMPLICATION |
14 |
0.0007 |
| 766 |
ACUTE RESPIRATORY FAILURE |
14 |
0.0007 |
| 767 |
STAPHYLOCOCCAL INFECTION |
24 |
0.0007 |
| 768 |
FLUID RETENTION |
37 |
0.0007 |
| 769 |
GLAUCOMA |
14 |
0.0007 |
| 770 |
URINARY TRACT INFECTION |
124 |
0.0007 |
| 771 |
GASTRITIS |
19 |
0.0007 |
| 772 |
DYSSTASIA |
21 |
0.0007 |
| 773 |
DYSPHONIA |
42 |
0.0007 |
| 774 |
ASTHENIA |
270 |
0.0007 |
| 775 |
OSTEOMYELITIS |
13 |
0.0007 |
| 776 |
OCULAR HYPERAEMIA |
34 |
0.0007 |
| 777 |
SKIN FISSURES |
14 |
0.0007 |
| 778 |
DRUG EFFECT INCOMPLETE |
26 |
0.0007 |
| 779 |
CELLULITIS |
36 |
0.0007 |
| 780 |
PERICARDITIS |
12 |
0.0007 |
| 781 |
TYPE 2 DIABETES MELLITUS |
24 |
0.0007 |
| 782 |
HYPOTENSION |
143 |
0.0007 |
| 783 |
CANDIDA INFECTION |
12 |
0.0007 |
| 784 |
LACTIC ACIDOSIS |
23 |
0.0007 |
| 785 |
EPISTAXIS |
53 |
0.0007 |
| 786 |
DIABETES MELLITUS |
54 |
0.0007 |
| 787 |
MUSCULOSKELETAL PAIN |
37 |
0.0007 |
| 788 |
PRESCRIBED UNDERDOSE |
14 |
0.0007 |
| 789 |
CHOLELITHIASIS |
23 |
0.0007 |
| 790 |
OEDEMA |
38 |
0.0007 |
| 791 |
PNEUMONIA |
225 |
0.0007 |
| 792 |
PULMONARY EMBOLISM |
66 |
0.0007 |
| 793 |
ULCER |
11 |
0.0007 |
| 794 |
RESPIRATORY TRACT INFECTION |
18 |
0.0007 |
| 795 |
HOSPITALISATION |
106 |
0.0007 |
| 796 |
COLITIS |
26 |
0.0007 |
| 797 |
BACK PAIN |
159 |
0.0007 |
| 798 |
ABDOMINAL PAIN |
159 |
0.0007 |
| 799 |
MUSCULOSKELETAL DISORDER |
13 |
0.0007 |
| 800 |
HOT FLUSH |
51 |
0.0007 |
| 801 |
CARDIOMYOPATHY |
10 |
0.0007 |
| 802 |
ACNE |
51 |
0.0007 |
| 803 |
PRODUCT USE IN UNAPPROVED INDICATION |
166 |
0.0007 |
| 804 |
EAR PAIN |
13 |
0.0007 |
| 805 |
DYSPNOEA EXERTIONAL |
25 |
0.0007 |
| 806 |
PRODUCT STORAGE ERROR |
58 |
0.0007 |
| 807 |
DEVICE USE ERROR |
23 |
0.0007 |
| 808 |
DEEP VEIN THROMBOSIS |
43 |
0.0007 |
| 809 |
SWELLING FACE |
43 |
0.0007 |
| 810 |
DYSGEUSIA |
49 |
0.0007 |
| 811 |
EYE PRURITUS |
22 |
0.0007 |
| 812 |
HIP FRACTURE |
21 |
0.0007 |
| 813 |
PAIN |
401 |
0.0007 |
| 814 |
ENCEPHALOPATHY |
16 |
0.0007 |
| 815 |
HEMIPARESIS |
11 |
0.0006 |
| 816 |
PREGNANCY |
13 |
0.0006 |
| 817 |
PROCEDURAL PAIN |
18 |
0.0006 |
| 818 |
HERPES ZOSTER |
37 |
0.0006 |
| 819 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
116 |
0.0006 |
| 820 |
INFECTION |
93 |
0.0006 |
| 821 |
EXTRA DOSE ADMINISTERED |
26 |
0.0006 |
| 822 |
TUBULOINTERSTITIAL NEPHRITIS |
12 |
0.0006 |
| 823 |
ADVERSE EVENT |
59 |
0.0006 |
| 824 |
PYREXIA |
221 |
0.0006 |
| 825 |
DRUG DOSE OMISSION BY DEVICE |
50 |
0.0006 |
| 826 |
COUGH |
179 |
0.0006 |
| 827 |
ALOPECIA |
124 |
0.0006 |
| 828 |
PAIN IN EXTREMITY |
186 |
0.0006 |
| 829 |
CARDIOVASCULAR DISORDER |
16 |
0.0006 |
| 830 |
PRODUCTIVE COUGH |
30 |
0.0006 |
| 831 |
TOOTH LOSS |
13 |
0.0006 |
| 832 |
EYE IRRITATION |
36 |
0.0006 |
| 833 |
RASH PAPULAR |
14 |
0.0006 |
| 834 |
BLISTER |
35 |
0.0006 |
| 835 |
TRANSIENT ISCHAEMIC ATTACK |
21 |
0.0006 |
| 836 |
HYPONATRAEMIA |
35 |
0.0006 |
| 837 |
EYE PAIN |
35 |
0.0006 |
| 838 |
ERUCTATION |
12 |
0.0006 |
| 839 |
ERYTHEMA |
127 |
0.0006 |
| 840 |
MOUTH ULCERATION |
13 |
0.0006 |
| 841 |
SWELLING |
57 |
0.0006 |
| 842 |
HAEMATOCRIT DECREASED |
12 |
0.0006 |
| 843 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
15 |
0.0006 |
| 844 |
FEBRILE NEUTROPENIA |
40 |
0.0006 |
| 845 |
PAIN IN JAW |
17 |
0.0006 |
| 846 |
MOBILITY DECREASED |
43 |
0.0006 |
| 847 |
MENSTRUATION IRREGULAR |
16 |
0.0006 |
| 848 |
CHILLS |
70 |
0.0006 |
| 849 |
CYSTITIS |
19 |
0.0006 |
| 850 |
RED BLOOD CELL COUNT DECREASED |
17 |
0.0006 |
| 851 |
ARTHRITIS |
46 |
0.0006 |
| 852 |
BURNING SENSATION |
41 |
0.0006 |
| 853 |
HAEMATURIA |
20 |
0.0006 |
| 854 |
INJURY |
41 |
0.0006 |
| 855 |
MYALGIA |
99 |
0.0006 |
| 856 |
MUSCULOSKELETAL STIFFNESS |
51 |
0.0006 |
| 857 |
SKIN EXFOLIATION |
49 |
0.0006 |
| 858 |
BLOOD URINE PRESENT |
11 |
0.0006 |
| 859 |
ILL-DEFINED DISORDER |
35 |
0.0006 |
| 860 |
ABDOMINAL DISTENSION |
60 |
0.0006 |
| 861 |
CEREBRAL INFARCTION |
14 |
0.0006 |
| 862 |
RASH PRURITIC |
31 |
0.0006 |
| 863 |
JOINT STIFFNESS |
15 |
0.0006 |
| 864 |
DYSURIA |
21 |
0.0006 |
| 865 |
OXYGEN SATURATION DECREASED |
32 |
0.0006 |
| 866 |
PSORIATIC ARTHROPATHY |
23 |
0.0006 |
| 867 |
BLOOD TRIGLYCERIDES INCREASED |
10 |
0.0006 |
| 868 |
EYE SWELLING |
21 |
0.0006 |
| 869 |
ACUTE KIDNEY INJURY |
86 |
0.0006 |
| 870 |
MENORRHAGIA |
11 |
0.0006 |
| 871 |
THROMBOSIS |
45 |
0.0006 |
| 872 |
COLITIS ULCERATIVE |
25 |
0.0006 |
| 873 |
HYPOACUSIS |
24 |
0.0006 |
| 874 |
FREQUENT BOWEL MOVEMENTS |
15 |
0.0006 |
| 875 |
DYSPNOEA |
314 |
0.0006 |
| 876 |
DIARRHOEA |
356 |
0.0006 |
| 877 |
STOMATITIS |
33 |
0.0005 |
| 878 |
VISUAL ACUITY REDUCED |
18 |
0.0005 |
| 879 |
DIVERTICULITIS |
15 |
0.0005 |
| 880 |
FUNGAL INFECTION |
18 |
0.0005 |
| 881 |
TRANSAMINASES INCREASED |
12 |
0.0005 |
| 882 |
DRY SKIN |
72 |
0.0005 |
| 883 |
RENAL INJURY |
16 |
0.0005 |
| 884 |
LYMPHADENOPATHY |
19 |
0.0005 |
| 885 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
14 |
0.0005 |
| 886 |
BLOOD SODIUM DECREASED |
10 |
0.0005 |
| 887 |
LIVER INJURY |
13 |
0.0005 |
| 888 |
HYPOKALAEMIA |
24 |
0.0005 |
| 889 |
ARTHRALGIA |
216 |
0.0005 |
| 890 |
PERICARDIAL EFFUSION |
12 |
0.0005 |
| 891 |
MATERNAL EXPOSURE DURING PREGNANCY |
46 |
0.0005 |
| 892 |
RASH MACULAR |
18 |
0.0005 |
| 893 |
ABDOMINAL PAIN LOWER |
13 |
0.0005 |
| 894 |
PANCREATITIS |
27 |
0.0005 |
| 895 |
VAGINAL HAEMORRHAGE |
22 |
0.0005 |
| 896 |
PERIPHERAL SWELLING |
78 |
0.0005 |
| 897 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
13 |
0.0005 |
| 898 |
INTESTINAL OBSTRUCTION |
19 |
0.0005 |
| 899 |
THERAPY INTERRUPTED |
36 |
0.0005 |
| 900 |
ABORTION SPONTANEOUS |
20 |
0.0005 |
| 901 |
INFUSION RELATED REACTION |
33 |
0.0005 |
| 902 |
RASH MACULO-PAPULAR |
11 |
0.0005 |
| 903 |
UNDERDOSE |
36 |
0.0005 |
| 904 |
BLOOD CREATININE INCREASED |
32 |
0.0005 |
| 905 |
OSTEOPOROSIS |
20 |
0.0005 |
| 906 |
RENAL FAILURE |
64 |
0.0005 |
| 907 |
NEEDLE ISSUE |
14 |
0.0005 |
| 908 |
LEUKOPENIA |
24 |
0.0005 |
| 909 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
17 |
0.0005 |
| 910 |
PRODUCT COMPLAINT |
12 |
0.0005 |
| 911 |
ATRIAL FIBRILLATION |
46 |
0.0005 |
| 912 |
ARTHROPATHY |
26 |
0.0005 |
| 913 |
HYPERGLYCAEMIA |
17 |
0.0005 |
| 914 |
FAECES DISCOLOURED |
10 |
0.0005 |
| 915 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
21 |
0.0004 |
| 916 |
INFLUENZA LIKE ILLNESS |
37 |
0.0004 |
| 917 |
SEPSIS |
50 |
0.0004 |
| 918 |
CEREBRAL HAEMORRHAGE |
16 |
0.0004 |
| 919 |
ABASIA |
11 |
0.0004 |
| 920 |
FLATULENCE |
25 |
0.0004 |
| 921 |
PNEUMONITIS |
12 |
0.0004 |
| 922 |
DEVICE LEAKAGE |
19 |
0.0004 |
| 923 |
MYOCARDIAL INFARCTION |
76 |
0.0004 |
| 924 |
HAEMATOCHEZIA |
24 |
0.0004 |
| 925 |
PREMATURE BABY |
13 |
0.0004 |
| 926 |
PANCYTOPENIA |
24 |
0.0004 |
| 927 |
WOUND |
12 |
0.0004 |
| 928 |
ANAPHYLACTIC SHOCK |
11 |
0.0004 |
| 929 |
CEREBROVASCULAR ACCIDENT |
72 |
0.0004 |
| 930 |
BLOOD GLUCOSE DECREASED |
20 |
0.0004 |
| 931 |
WHITE BLOOD CELL COUNT DECREASED |
45 |
0.0004 |
| 932 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
14 |
0.0004 |
| 933 |
SEPTIC SHOCK |
18 |
0.0004 |
| 934 |
HYPOGLYCAEMIA |
20 |
0.0004 |
| 935 |
OEDEMA PERIPHERAL |
50 |
0.0004 |
| 936 |
BLOOD BILIRUBIN INCREASED |
11 |
0.0004 |
| 937 |
BLOOD PRESSURE DECREASED |
27 |
0.0004 |
| 938 |
RHEUMATOID ARTHRITIS |
46 |
0.0004 |
| 939 |
LOWER RESPIRATORY TRACT INFECTION |
18 |
0.0004 |
| 940 |
HAEMORRHAGE |
41 |
0.0004 |
| 941 |
WHEEZING |
23 |
0.0004 |
| 942 |
EXPOSURE VIA SKIN CONTACT |
10 |
0.0004 |
| 943 |
C-REACTIVE PROTEIN INCREASED |
14 |
0.0004 |
| 944 |
NEUTROPENIA |
52 |
0.0004 |
| 945 |
LABORATORY TEST ABNORMAL |
11 |
0.0004 |
| 946 |
RENAL IMPAIRMENT |
31 |
0.0004 |
| 947 |
IMPAIRED HEALING |
12 |
0.0004 |
| 948 |
HEPATIC FAILURE |
11 |
0.0004 |
| 949 |
PLASMA CELL MYELOMA |
14 |
0.0004 |
| 950 |
BONE DENSITY DECREASED |
11 |
0.0004 |
| 951 |
INFLAMMATION |
18 |
0.0003 |
| 952 |
THROMBOCYTOPENIA |
39 |
0.0003 |
| 953 |
ANAEMIA |
66 |
0.0003 |
| 954 |
NEOPLASM PROGRESSION |
12 |
0.0003 |
| 955 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
17 |
0.0003 |
| 956 |
BONE PAIN |
19 |
0.0003 |
| 957 |
SKIN BURNING SENSATION |
23 |
0.0003 |
| 958 |
INJECTION SITE REACTION |
22 |
0.0003 |
| 959 |
BLINDNESS |
13 |
0.0003 |
| 960 |
RESPIRATORY FAILURE |
23 |
0.0003 |
| 961 |
PSORIASIS |
39 |
0.0003 |
| 962 |
LIVER DISORDER |
13 |
0.0003 |
| 963 |
DISEASE PROGRESSION |
34 |
0.0003 |
| 964 |
INJECTION SITE PRURITUS |
19 |
0.0003 |
| 965 |
RENAL DISORDER |
13 |
0.0003 |
| 966 |
CARDIAC DISORDER |
26 |
0.0003 |
| 967 |
INJECTION SITE PAIN |
85 |
0.0003 |
| 968 |
JOINT SWELLING |
32 |
0.0003 |
| 969 |
MALIGNANT NEOPLASM PROGRESSION |
27 |
0.0003 |
| 970 |
INJECTION SITE BRUISING |
21 |
0.0003 |
| 971 |
DEATH |
226 |
0.0003 |
| 972 |
CARDIAC FAILURE |
21 |
0.0003 |
| 973 |
BLOOD GLUCOSE INCREASED |
49 |
0.0003 |
| 974 |
DEVICE MALFUNCTION |
18 |
0.0003 |
| 975 |
PLATELET COUNT DECREASED |
27 |
0.0003 |
| 976 |
CARDIAC FAILURE CONGESTIVE |
20 |
0.0002 |
| 977 |
PLEURAL EFFUSION |
15 |
0.0002 |
| 978 |
BREAST CANCER |
22 |
0.0002 |
| 979 |
LUNG DISORDER |
11 |
0.0002 |
| 980 |
INJECTION SITE SWELLING |
17 |
0.0002 |
| 981 |
HAEMOGLOBIN DECREASED |
22 |
0.0002 |
| 982 |
DEPENDENCE |
11 |
0.0002 |
| 983 |
GENERAL PHYSICAL HEALTH DETERIORATION |
23 |
0.0002 |
| 984 |
INJECTION SITE ERYTHEMA |
23 |
0.0002 |
| 985 |
NEOPLASM MALIGNANT |
11 |
0.0002 |
| 986 |
GASTROINTESTINAL HAEMORRHAGE |
11 |
0.0001 |